Literature DB >> 19653001

Clinical and radiographic findings in two brothers affected with a novel mutation in matrix metalloproteinase 2 gene.

Faysal Gok1, Lauréane Mittaz Crettol, Yasemin Alanay, Bulent Hacihamdioglu, Murat Kocaoglu, Luisa Bonafe, Seza Ozen.   

Abstract

The two well-described osteolysis syndromes associated with matrix metalloproteinase-2 deficiency and mutations in the metalloproteinase-2 gene are Torg-Winchester syndrome and nodulosis-arthropathy-osteolysis variant. They are characterized by carpal-tarsal destruction, subcutaneous nodules, and generalized osteoporosis and show autosomal recessive inheritance. Herein, we report two siblings affected with a novel mutation in matrix metalloproteinase 2 gene and discuss their clinical and radiographic findings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653001     DOI: 10.1007/s00431-009-1028-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome.

Authors:  J A Martignetti; A A Aqeel; W A Sewairi; C E Boumah; M Kambouris; S A Mayouf; K V Sheth; W A Eid; O Dowling; J Harris; M J Glucksman; S Bahabri; B F Meyer; R J Desnick
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

Review 2.  Extracellular matrix remodelling: the role of matrix metalloproteinases.

Authors:  Ivan Stamenkovic
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

3.  Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth.

Authors:  Rebecca A Mosig; Oonagh Dowling; Analisa DiFeo; Maria Celeste M Ramirez; Ian C Parker; Etsuko Abe; Janane Diouri; Aida Al Aqeel; James D Wylie; Samantha A Oblander; Joseph Madri; Paolo Bianco; Suneel S Apte; Mone Zaidi; Stephen B Doty; Robert J Majeska; Mitchell B Schaffler; John A Martignetti
Journal:  Hum Mol Genet       Date:  2007-03-30       Impact factor: 6.150

4.  Chronic nephropathy in idiopathic multicentric osteolysis.

Authors:  M Hirooka; M Hirota
Journal:  Int J Pediatr Nephrol       Date:  1985 Apr-Jun

5.  Torg syndrome is caused by inactivating mutations in MMP2 and is allelic to NAO and Winchester syndrome.

Authors:  Andreas Zankl; Lauren Pachman; Andrew Poznanski; Luisa Bonafé; Fengqiang Wang; Yelena Shusterman; David A Fishman; Andrea Superti-Furga
Journal:  J Bone Miner Res       Date:  2007-02       Impact factor: 6.741

6.  Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen.

Authors:  W Zhao; M H Byrne; Y Wang; S M Krane
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

7.  Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2.

Authors:  A Zankl; L Bonafé; V Calcaterra; M Di Rocco; A Superti-Furga
Journal:  Clin Genet       Date:  2005-03       Impact factor: 4.438

8.  Inherited multicentric osteolysis with carpal-tarsal localisation mimicking juvenile idiopathic arthritis.

Authors:  Marianne R Faber; René Verlaak; Theo J W Fiselier; Ben C J Hamel; Marcel J A M Franssen; G Peter J M Gerrits
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

9.  A novel homozygous MMP2 mutation in a family with Winchester syndrome.

Authors:  C Rouzier; R Vanatka; S Bannwarth; N Philip; A Coussement; V Paquis-Flucklinger; J-C Lambert
Journal:  Clin Genet       Date:  2006-03       Impact factor: 4.438

10.  Absence of MMP2 mutation in idiopathic multicentric osteolysis with nephropathy.

Authors:  Deborah Wenkert; Steven Mumm; Stefanie M Wiegand; William H McAlister; Michael P Whyte
Journal:  Clin Orthop Relat Res       Date:  2007-09       Impact factor: 4.176

View more
  6 in total

1.  Differential effects between the loss of MMP-2 and MMP-9 on structural and tissue-level properties of bone.

Authors:  Jeffry S Nyman; Conor C Lynch; Daniel S Perrien; Sophie Thiolloy; Elizabeth C O'Quinn; Chetan A Patil; Xiaohong Bi; George M Pharr; Anita Mahadevan-Jansen; Gregory R Mundy
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

2.  Functional characterisation of a novel mutation affecting the catalytic domain of MMP2 in siblings with multicentric osteolysis, nodulosis and arthropathy.

Authors:  Jacopo Azzollini; Davide Rovina; Cristina Gervasini; Ilaria Parenti; Alessia Fratoni; Maria Vittoria Cubellis; Amilcare Cerri; Luca Pietrogrande; Lidia Larizza
Journal:  J Hum Genet       Date:  2014-10-02       Impact factor: 3.172

Review 3.  Multicentric osteolysis with nodulosis and arthropathy (MONA) with cardiac malformation, mimicking polyarticular juvenile idiopathic arthritis: case report and literature review.

Authors:  Filip Christian Castberg; Susanne Kjaergaard; Rebecca A Mosig; Mollie Lobl; Chiara Martignetti; John A Martignetti; Charlotte Myrup; Marek Zak
Journal:  Eur J Pediatr       Date:  2013-07-31       Impact factor: 3.183

Review 4.  The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.

Authors:  Stefano Stagi; Loredana Cavalli; Salvatore Seminara; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2014-06-07       Impact factor: 2.638

5.  Bisphosphonates in multicentric osteolysis, nodulosis and arthropathy (MONA) spectrum disorder - an alternative therapeutic approach.

Authors:  Karin Pichler; Daniela Karall; Dieter Kotzot; Elisabeth Steichen-Gersdorf; Alexandra Rümmele-Waibel; Laureane Mittaz-Crettol; Julia Wanschitz; Luisa Bonafé; Kathrin Maurer; Andrea Superti-Furga; Sabine Scholl-Bürgi
Journal:  Sci Rep       Date:  2016-09-30       Impact factor: 4.379

6.  Multicentric Osteolysis, Nodulosis, and Arthropathy in two unrelated children with matrix metalloproteinase 2 variants: Genetic-skeletal correlations.

Authors:  Hanan Elsebaie; Mohamed Abdelhafiz Mansour; Solaf M Elsayed; Shady Mahmoud; Tamer A El-Sobky
Journal:  Bone Rep       Date:  2021-07-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.